COVID-19: Protection of IP for AI tools
01-09-2020
EU reaches first COVID-19 vaccine deal
17-08-2020
GrooveZ / Shutterstock.com
Antimicrobial company PureShield has accused its competitor Allied BioScience of infringing ten patents through the sale of a surface disinfectant, which claims protection against COVID-19 for up to seven days.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
PureShield, Allied BioScience, patent infringement, disinfectants, COVID-19, EPA, antimicrobial, coronavirus
